Page last updated: 2024-09-05

sb 203580 and Coronary Restenosis

sb 203580 has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dawson, KA; Gallagher, WM; Hickey, JA; Keenan, AK; McGillicuddy, FC; O'Toole, D	1

Other Studies

1 other study(ies) available for sb 203580 and Coronary Restenosis

Article	Year
TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascular pharmacology, 2006, Volume: 44, Issue:6 Topics: Adult; Cells, Cultured; Coronary Restenosis; Coronary Vessels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RNA, Messenger; Thrombospondin 1; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006

Article

Year

TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.

Vascular pharmacology, 2006, Volume: 44, Issue:6

Topics: Adult; Cells, Cultured; Coronary Restenosis; Coronary Vessels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RNA, Messenger; Thrombospondin 1; Transforming Growth Factor beta; Transforming Growth Factor beta1

2006